| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6184861 | Gynecologic Oncology | 2015 | 8 Pages |
Abstract
VBT decreases the risk of recurrence with minimal toxicity in the adjuvant treatment of endometrial cancer. Adjuvant therapy should be discussed in a multi-disciplinary setting with detailed counseling of the risks and benefits with the patient so that she ultimately makes an informed decision regarding her adjuvant therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Matthew M. Harkenrider, Alec M. Block, Zaid A. Siddiqui, William Jr.,